Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

- Foong, Yi Chao, Merlo, Daniel, Patti, Francesco, Grammond, Pierre, Amato, Maria Pia, Kalincik, Tomas, Horakova, Dana, Kubala Havrdova, Eva, Weinstock-Guttman, Bianca, Lechner Scott, Jeanette, Boz, Cavit, Sa, Maria, Gresle, Melissa, Butzkueven, H, van der Walt, A, Zhu, C, MSBASE study group,, Buzzard, Katherine, Zhong, Michael, Yeh, Wei Zhen, Jokubaitis, Vilija, Monif, Mastura, Skibina, Olga, Ozakbas, Serkan

Patient-determined disease steps is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis

- Foong, Yi Chao, Merlo, Daniel, Darby, David, Dobay, Pamela, van Beek, Johan, Hyde, Robert, Butzkueven, Helmut, van der Walt, Anneke, Gresle, Melissa, Zhu, Chao, Buzzard, Katherine, Lechner-Scott, Jeannette, Barnett, Michael, Taylor, Bruce, Kalincik, Tomas, Kilpatrick, Trevor

The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial

- Yeh, Wei Zhen, Gresle, Melissa, Sampangi, Sandeep, Campagna, Maria Pia, Stankovich, Jim, Van der Walt, Anneke, Jokubaitis, Vilija, Butzkueven, Helmut, Lea, Rodney, Taylor, Bruce, Lucas, Robyn M., Ponsonby, Anne-Louise, Mason, Deborah, Andrew, Julie, Campbell, Hamish, Morahan, Julia

Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis

- Yeh, Wei Z., Lea, Rodney, Stankovich, Jim, Sampangi, Sandeep, Laverick, Louise, Van der Walt, Anneke, Jokubaitis, Vilija, Gresle, Melissa, Butzkueven, Helmut

Association between cognitive trajectories and disability progression in patients with relapsing-remitting multiple sclerosis

- Merlo, Daniel, Stankovich, Jim, Darby, David, Butzkueven, Helmut, Van der Walt, Anneke, Bai, Claire, Kalincik, Tomas, Zhu, Chao, Gresle, Melissa, Lechner-Scott, Jeannette, Kilpatrick, Trevor, Barnett, Michael, Taylor, Bruce

Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients

- Maltby, Vicki E., Lea, Rodney A., Burnard, Sean, Xavier, Alexandre, Van Cao, Thao, White, Nicole, Kennedy, Daniel, Groen, Kira, Sanders, Katherine A., Seeto, Rebecca, Bray, Samara, Gresle, Melissa, Laverick, Louise, Butzkueven, Helmut, Scott, Rodney J., Lechner-Scott, Jeannette

The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis

- Yam, Charmaine, Merlo, Daniel, Stankovich, Jim, Darby, David, Gresle, Melissa, Kalincik, Tomas, Kilpatrick, Trevor J., Lechner-Scott, Jeanette, Taylor, Bruce, Barnett, Michael, Butzkueven, Helmut, van der Walt, Anneke

A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis

- Gu, Ben J., Field, Judith, Butzkueven, Helmut, Gresle, Melissa, Laws, Simon M., Petrou, Steven, Hoffjan, Sabine, Akkad, Denis A., Graham, Colin A., Hawkins, Stanley, Glaser, Anna, Bedri, Sahl Khalid, Dutertre, Sébastien, Hillert, Jan, Matute, Carlos, Antiguedad, Alfredo, Wiley, James S., Ou, Amber, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Scott, Rodney, Lea, Rodney, Taylor, Bruce V., Stankovich, Jim

The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function

- Field, Judith, Shahijanian, Fernando, Butzkueven, Helmut, Booth, David, Baxter, Alan, Kermode, Allan G., Taylor, Bruce, Booth, David R., Mason, Deborah, Stewart, Graeme J., Charlesworth, Jac, Schibeci, Stephen, Wiley, James, Lechner-Scott, Jeannette, Tajouri, Lotti, Griffiths, Lyn, Slee, Mark, Brown, Matthew A., Moscato, Pablo, Scott, Rodney J., Broadley, Simon, Johnson, Laura, Vucic, Steve, Kilpatrick, Trevor, Carroll, William M., Gresle, Melissa, Laverick, Louise, Parnell, Grant, Stewart, Graeme, McKay, Fiona